Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Clinical performance of two commercial PCR assays for the detection of macrolide resistance in Mycoplasma pneumoniae.

Journal of clinical microbiology - 11 Mar 2026

Hénin Nadège, Silvant Alicia, Gardette Marie, Balcon Carla, Guiraud Jennifer, Bébéar Cécile, Pereyre Sabine

Abstract excerpt

Macrolides are the first-line treatment for Mycoplasma pneumoniae infections; however, macrolide resistance has been reported. We evaluated the clinical performance of two commercial assays for detecting macrolide-resistant M. pneumoniae: the LightMix Modular Mycoplasma Macrolide (TIB Molbiol) and the Mycoplasma Pneumoniae and Macrolides-Resistant Strain Nucleic Acid Test Kit (Mole Bioscience), using 23S rRNA...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Drug Resistance, Bacterial
Share to Macrolides

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Microbial Sensitivity Tests

Share to Mycoplasma pneumoniae

Share to Pneumonia, Mycoplasma

Share to Reagent Kits, Diagnostic

Share to RNA, Ribosomal, 23S

Share to Sensitivity and Specificity

Source

Open in PubMed Open full text

Identifiers

PMID: 41685926
DOI: 10.1128/jcm.01491-25
PMCID: PMC12977576

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Clinical performance of two commercial PCR assays for the detection of macrolide resistance in Mycoplasma pneumoniae.PMID 41685926Read ↗

Multiplex amplicon sequencing reveals polyclonality and low macrolide resistance in the French Mycoplasma pneumoniae outbreak, 2023-2024.Semantic proximity Read ↗

A one-pot, visual, multiplex microfluidic digital PCR chip for simultaneous point-of-care detection, genotyping, and macrolide resistance assessment of Mycoplasma pneumoniae.Semantic proximity Read ↗

Clinical features of macrolide-resistant Mycoplasma pneumoniae pneumonia: Can the JRS pneumonia guidelines be applied?Semantic proximity Read ↗

Association analysis of Mycoplasma pneumoniae 23S rRNA gene mutation with refractory Mycoplasma pneumoniae pneumonia in children.Semantic proximity Read ↗

Macrolide-resistant Mycoplasma pneumoniae in humans, Ontario, Canada, 2010-2011.Semantic proximity Read ↗

Multicenter analysis of the Mycoplasma pneumoniae resurgence in China 2023-2024.Semantic proximity Read ↗

Epidemiology and high-level macrolide resistance of Mycoplasma pneumoniae among children in Hangzhou, China: a 2024–2025 single-center surveillance studySemantic proximity Read ↗

Antimicrobial susceptibility and genotyping of Mycoplasma pneumoniae isolates in Beijing, China, from 2014 to 2016Semantic proximity Read ↗

Evaluation of GENECUBE Mycoplasma for the detection of macrolide-resistant Mycoplasma pneumoniae.Semantic proximity Read ↗

[Determination of Gene Mutations Associated with Macrolide and Fluoroquinolone Resistance in Patients Infected with Mycoplasma genitalium].Semantic proximity Read ↗

Correlation Analysis of DNA Load, Drug-resistant Mutations and Clinical Manifestation of Mycoplasma pneumoniae Infection in ChildrenSemantic proximity Read ↗

Molecular Characterization of Mycoplasma pneumoniae Isolates in the United States from 2012 to 2018.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.